LPL Financial »

Aligos Therapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $540k 55k 9.80
2025-06-30 $217k 30k 7.21

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Series Trust Portfolio S&p500 (SPLG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
Vanguard Index Fds Growth Etf (VUG)

View all positions for LPL Financial

Top funds holding Aligos Therapeutics

Woodline Partners
Deep Track Capital
Alyeska Investment Group
Sio Capital Management
Readystate Asset Management
Vanguard Group
Adage Capital Partners GP
Baker Bros. Advisors
Hillhouse Capital Advisors
LPL Financial
Renaissance Technologies
Geode Capital Management
Two Sigma Investments
Squarepoint Ops
UBS Group

View all funds holding Aligos Therapeutics